NeuroImage ClinicalNeurosciencePeer-reviewed journal article
Creation of an Open Science Dataset from PREVENT-AD, a Longitudinal Cohort Study of Pre-symptomatic Alzheimer's Disease.
Jennifer Tremblay‐MercieriD, Cécile MadjariD, Samir DasiD, Alexa Pichet BinetteiD, Stephanie O. M. DykeiD, Pierre E EtienneiD, Marie‐Élyse Lafaille‐Magnan, Jordana Remz, Pierre BelleciD, D. Louis CollinsiD, Maria Natasha RajahiD, Véronique D. BohbotiD, Jeannie‐Marie LeoutsakosiD, Yasser Iturria‐MedinaiD, Justin Kat, Richard D. HogeiD, Serge G. GauthieriD, Christine Lucas TardifiD, M. Mallar ChakravartyiD, Jean‐Baptiste PolineiD, Pedro Rosa‐NetoiD, Alan Charles EvansiD, Sylvia VilleneuveiD, Judes PoirieriD, John C.S. BreitneriD
Abstract
To move Alzheimer Disease (AD) research forward it is essential to collect data from large cohorts, but also make such data available to the global research community. We describe the creation of an open science dataset from the PREVENT-AD (PResymptomatic EValuation of Experimental or Novel Treatments for AD) cohort, composed of cognitively unimpaired older individuals with a parental or multiple-sibling history of AD. From 2011 to 2017, 386 participants were enrolled (mean age 63 years old {+/-} 5) for sustained investigation among whom 349 have retrospectively agreed to share their data openly. Repositories are findable through the unified interface of the Canadian Open Neuroscience Platform (https://portal.conp.ca/) and contain up to five years of longitudinal imaging data, cerebral fluid biochemistry, neurosensory capacities, cognitive, genetic, and medical information. Imaging data can be accessed openly at https://openpreventad.loris.ca while most of the other information, sensitive by nature, is accessible by qualified researchers at https://registeredpreventad.loris.ca. In addition to being a living resource for continued data acquisition, PREVENT-AD offers opportunities to facilitate understanding of AD pathogenesis.
- organism: human
- assay: imaging
- assay: proteomics
- assay: metagenomics
- assay: DNA methylation
- research focus: database / resource
- research focus: benchmarking
- Citations
- 109
- FWCI
- 10.93
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- NTAD: A longitudinal neuroimaging dataset of Alzheimer's disease pathology
Mats W.J. van Es, Marlou Nadine Perquin, … the NTAD study group·bioRxiv·Nov 3, 2026
- Neuroimaging within the Dominantly Inherited Alzheimer's Network (DIAN): PET and MRI
Nicole Sarah McKay, Brian Andrew Gordon, … Dominantly Inherited Alzheimer Network·bioRxiv·Mar 25, 2022
- The Wisconsin Registry for Alzheimer’s Prevention: A Review of findings and current directions
Sterling C. Johnson, Rebecca L. Koscik, … Mark A. Sager·Alzheimer s & Dementia Diagnosis Assessment & Disease MonitoringPeer-reviewed·Dec 8, 2017
- Adolescent Brain Cognitive Development (ABCD) Community MRI Collection and Utilities
Eric Feczko, Greg Conan, … Damien A. Fair·bioRxiv·Jul 9, 2021
- The Advanced BRain Imaging on ageing and Memory (ABRIM) data collection: Study protocol and rationale
Michelle G. Jansen, Marcel P. Zwiers, … David Gordon Norris·PLoS ONEPeer-reviewed·Jun 21, 2024
- NIAGADS: A Comprehensive National Data Repository for Alzheimer's Disease and Related Dementia Genetics and Genomics Research
Amanda B. Kuzma, Otto Valladares, … Li‐San Wang·medRxiv·Oct 7, 2024